These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 37626568)

  • 1. Imaging Markers in Genetic Forms of Parkinson's Disease.
    Droby A; Thaler A; Mirelman A
    Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Imaging Markers of Prodromal Parkinson's Disease.
    Hustad E; Aasly JO
    Front Neurol; 2020; 11():395. PubMed ID: 32457695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.
    Winogrodzka A; Wagenaar RC; Bergmans P; Vellinga A; Booij J; van Royen EA; van Emmerik RE; Stoof JC; Wolters EC
    Mov Disord; 2001 Nov; 16(6):1033-40. PubMed ID: 11748734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress in the early diagnosis of Parkinson's disease.
    Xie L; Hu L
    Neurol Sci; 2022 Nov; 43(11):6225-6231. PubMed ID: 35948779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor.
    Wang XX; Feng Y; Li X; Zhu XY; Truong D; Ondo WG; Wu YC
    Front Neurol; 2020; 11():874. PubMed ID: 32982913
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroimaging of Parkinson's disease: Expanding views.
    Weingarten CP; Sundman MH; Hickey P; Chen NK
    Neurosci Biobehav Rev; 2015 Dec; 59():16-52. PubMed ID: 26409344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.
    Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A
    Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational molecular imaging and drug development in Parkinson's disease.
    Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
    Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease.
    Martín-Bastida A; Delgado-Alvarado M; Navalpotro-Gómez I; Rodríguez-Oroz MC
    Front Neurol; 2021; 12():733570. PubMed ID: 34803882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography neuroimaging in Parkinson's disease.
    Loane C; Politis M
    Am J Transl Res; 2011 Aug; 3(4):323-41. PubMed ID: 21904653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation and Mitochondrial Dysfunction in Parkinson's Disease: Connecting Neuroimaging with Pathophysiology.
    Pizarro-Galleguillos BM; Kunert L; Brüggemann N; Prasuhn J
    Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear imaging in Parkinson's disease: The past, the present, and the future.
    Golan H; Volkov O; Shalom E
    J Neurol Sci; 2022 May; 436():120220. PubMed ID: 35313223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Markers of Progression in Parkinson's Disease.
    Strafella AP; Bohnen NI; Pavese N; Vaillancourt DE; van Eimeren T; Politis M; Tessitore A; Ghadery C; Lewis S;
    Mov Disord Clin Pract; 2018; 5(6):586-596. PubMed ID: 30637278
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.